Quick Summary:
In the rapidly advancing healthcare sector, the global market for Heart Valve Repair and Replacement Devices is projected to break new ground. A significant swell in investment, supported by state-of-the-art technology, is set to steer this market from a valuation of US$12.9 Billion in 2022 to an astounding US$40.9 Billion by 2030. This comprehensive market research report provides an in-depth analysis of both present status and future prospects of this burgeoning market.
The report offers an invaluable insight into diverse market segments, including Transcatheter Surgery and Open Surgery. With granular attention to key geographical regions like the U.S., China, Japan, Canada, and Germany, the study aims to give businesses a strategic edge in the Heart Valve Repair and Replacement Devices market. Discover the future growth areas, strengthening your understanding of the competitive landscape featuring giants like Abbott Laboratories, Boston Scientific Corporation, and Medtronic PLC.
Global Heart Valve Repair and Replacement Devices Market to Reach $40.9 Billion by 2030
The global market for Heart Valve Repair and Replacement Devices estimated at US$12.9 Billion in the year 2022, is projected to reach a revised size of US$40.9 Billion by 2030, growing at a CAGR of 15.5% over the analysis period 2022-2030. Transcatheter Surgery, one of the segments analyzed in the report, is projected to record 14% CAGR and reach US$20.2 Billion by the end of the analysis period. Taking into account the ongoing post pandemic recovery, growth in the Open Surgery segment is readjusted to a revised 17.3% CAGR for the next 8-year period.
The U.S. Market is Estimated at $3.4 Billion, While China is Forecast to Grow at 19.6% CAGR
The Heart Valve Repair and Replacement Devices market in the U.S. is estimated at US$3.4 Billion in the year 2022. China, the world's second largest economy, is forecast to reach a projected market size of US$10.2 Billion by the year 2030 trailing a CAGR of 19.6% over the analysis period 2022 to 2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 11.2% and 13.4% respectively over the 2022-2030 period. Within Europe, Germany is forecast to grow at approximately 12.2% CAGR.Select Competitors (Total 17 Featured) -
- Abbott Laboratories
- Ancora Heart Inc.
- Balton Sp z o.o.
- Becton, Dickinson and Company
- BioStable Science & Engineering, Inc.
- Boston Scientific Corporation
- Cardiac Dimensions Pty. Ltd.
- Colibri Heart Valve LLC
- CryoLife, Inc.
- Edwards Lifesciences Corporation
- JenaValve Technology GmbH
- Lepu Medical Technology (Beijing) Co., Ltd.
- LivaNova PLC
- Mardil Medical Inc.
- Medtronic PLC
- Micro Interventional Devices, Inc.
- Millipede, Inc.
- Mitralign Inc.
- MVRx, Inc.
- NeoChord, Inc.
- Toray Industries, Inc.
- Valcare Medical
- Venus Medtech (Hangzhou) Inc.
What's New?
- Special coverage on Russia-Ukraine war; global inflation; easing of zero-Covid policy in China and its `bumpy` reopening; supply chain disruptions, global trade tensions; and risk of recession.
- Global competitiveness and key competitor percentage market shares
- Market presence across multiple geographies - Strong/Active/Niche/Trivial
- Online interactive peer-to-peer collaborative bespoke updates
- Access to digital archives and Research Platform
- Complimentary updates for one year
What is the estimated value of the Global Market for Heart Valve Repair and Replacement Devices?
What is the growth rate of the Global Market for Heart Valve Repair and Replacement Devices?
What is the forecasted size of the Global Market for Heart Valve Repair and Replacement Devices?
Who are the key companies in the Global Market for Heart Valve Repair and Replacement Devices?
| Report Attribute | Details |
|---|---|
| No. of Pages | 182 |
| Published | September 2023 |
| Forecast Period | 2022 - 2030 |
| Estimated Market Value ( USD | $ 12.9 Billion |
| Forecasted Market Value ( USD | $ 40.9 Billion |
| Compound Annual Growth Rate | 15.5% |
| Regions Covered | Global |
Table of Contents
Companies Mentioned
A selection of companies mentioned in this report includes:
- Abbott Laboratories
- Ancora Heart Inc.
- Balton Sp z o.o.
- Becton, Dickinson and Company
- BioStable Science & Engineering, Inc.
- Boston Scientific Corporation
- Cardiac Dimensions Pty. Ltd.
- Colibri Heart Valve LLC
- CryoLife, Inc.
- Edwards Lifesciences Corporation
- JenaValve Technology GmbH
- Lepu Medical Technology (Beijing) Co., Ltd.
- LivaNova PLC
- Mardil Medical Inc.
- Medtronic PLC
- Micro Interventional Devices, Inc.
- Millipede, Inc.
- Mitralign Inc.
- MVRx, Inc.
- NeoChord, Inc.
- Toray Industries, Inc.
- Valcare Medical
- Venus Medtech (Hangzhou) Inc.
